Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia

Click to increase image sizeClick to decrease image size

Author contributions

SK designed the research study, collected and analyzed the data, wrote the first draft of the manuscript.

SD collected the data and critically revised the manuscript.

PP collected infection data and critically revised the manuscript.

SH analyzed, interpreted the data and critically revised the manuscript.

DA interpreted the data and critically revised the manuscript.

All authors verified and approved the final version of the manuscript.

Disclosure statement

None of the authors have any conflicts of interest to declare.

Data availability statement

Raw data were generated at Hull University Teaching Hospitals NHS Trust. Derived data supporting the findings of this study are available from the corresponding author on request.